SCHEMBL7102443

SCHEMBL7102443

CCN(C(=O)NC1CC1)C1CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
ADRA2A P08913 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KMT2A Q03164 1/20 0.37
EPHX2 P34913 1/20 0.34
KDM4E B2RXH2 3/20 0.34
EPHX1 P07099 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
PDE4A P27815 1/20 0.34
ADRA1A P35348 1/20 0.34
CCR5 P51681 2/20 0.34
NPC1 O15118 1/20 0.34
DRD2 P14416 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MMP2 P08253 1/20 0.33
MMP8 P22894 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL965716 0.79 CCR5 (0.39) ALDH1A1KMT2AKDM4EL3MBTL1CCR5
SCHEMBL25480523 0.78 L3MBTL1 (0.35) ALDH1A1KMT2AKDM4EL3MBTL1CCR5
SCHEMBL965813 0.78 CCR5 (0.39) ALDH1A1KMT2AKDM4EEPHX1L3MBTL1
SCHEMBL11044933 0.77 DRD2 (0.47) ALDH1A1ADRA2ASMN1; SMN2KMT2AEPHX2
SCHEMBL11049209 0.77 DRD2 (0.47) ALDH1A1ADRA2ASMN1; SMN2KMT2AEPHX2
SCHEMBL9547544 0.76 EPHX2 (0.41) ALDH1A1ADRA2ASMN1; SMN2KMT2AEPHX2
SCHEMBL5987335 0.76 EPHX2 (0.40) ALDH1A1ADRA2ASMN1; SMN2EPHX2KDM4E
SCHEMBL23135929 0.74 CCR5 (0.44) ALDH1A1KMT2AKDM4EEPHX1L3MBTL1
SCHEMBL969305 0.73 L3MBTL1 (0.41) ALDH1A1KMT2AKDM4EL3MBTL1CCR5
SCHEMBL7024470 0.72 NPY5R (0.49) CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042730-A1 Substituted Arylketones HERRMANN STEFAN 2009-02-12 US disclosed
US-7456133-B2 Substituted arylketones BAYER CROPSCIENCE AG (DE) 2008-11-25 US disclosed
US-6531600-B1 8-substituted xanthines have a protective effect against the consequences of cerebral metabolic inhibition; cerebral vascular and neuronal degenerative disorders; 6-aminouracil intermediate is claimed BEECHAM GROUP P.L.C. (GB) 2003-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042730-A1 Substituted Arylketones CYP1A1, CYP1B1, CYP1A2 ALDH1A1 37/4885ADRA2A 310/4885SMN1; SMN2 3889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.